Adherence to NCCN Guidelines for Genetic Testing in Breast Cancer Patients: Who Are We Missing?

被引:0
|
作者
J. Jaime Alberty-Oller
Sarah Weltz
Antonio Santos
Kereeti Pisapati
Meng Ru
Christina Weltz
Hank Schmidt
Elisa Port
机构
[1] Mount Sinai Hospital,Dubin Breast Center, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:281 / 286
页数:5
相关论文
共 50 条
  • [1] Adherence to NCCN Guidelines for Genetic Testing in Breast Cancer Patients: Who are We Missing?
    Alberty-Oller, J.
    Weltz, S.
    Santos, A.
    Pisapati, K.
    Miller, A.
    Ru, M.
    Weltz, C.
    Schmidt, H.
    Port, E.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : S83 - S83
  • [2] Adherence to NCCN Guidelines for Genetic Testing in Breast Cancer Patients: Who Are We Missing?
    Alberty-Oller, J. Jaime
    Weltz, Sarah
    Santos, Antonio
    Pisapati, Kereeti
    Ru, Meng
    Weltz, Christina
    Schmidt, Hank
    Port, Elisa
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (01) : 281 - 286
  • [3] Adherence to NCCN Genetic Testing Guidelines in Pancreatic Cancer and Impact on Treatment
    Crowley, Fionnuala
    Gandhi, Sonal
    Rudshteyn, Michelle
    Sehmbhi, Mantej
    Cohen, Deirdre J.
    ONCOLOGIST, 2023, 28 (06): : 486 - 493
  • [4] NCCN Guidelines for breast cancer: How compliant are we?
    Merritt, Clay M.
    Heidenreich, Bethany M.
    Durkee, Andrew S.
    Abuhakmeh, Yousef H.
    Hofmann, Luke J.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : 383 - 384
  • [5] Assessing the effectiveness of the NCCN genetic testing guidelines in identifying African American breast cancer patients with deleterious genetic mutations
    Ademuyiwa, Foluso O.
    Salyer, Patricia
    Ma, Yinjiao
    Fisher, Sherri
    Colditz, Graham
    Weilbaecher, Katherine
    Bierut, Laura J.
    CANCER RESEARCH, 2020, 80 (04)
  • [6] Evaluation of adherence to NCCN guidelines regarding genetic evaluation of patients with breast or ovarian cancer diagnoses in a community hospital setting
    King, Kristine M.
    Huffaker, Shannon
    Froman, Dione
    CANCER RESEARCH, 2020, 80 (04)
  • [7] Screening for Genetic Testing in Breast Cancer - Are We Missing the Full Picture?
    McCormick, G.
    Mikropoulos, C.
    Sadler, G.
    Abson, C.
    Davis, A.
    Hall, J.
    CLINICAL ONCOLOGY, 2016, 28 (03) : 226 - 226
  • [8] COMPLIANCE WITH THE NCCN GUIDELINES IN THE STAGING OF BREAST CANCER PATIENTS
    Alfotih, S.
    Alqurashi, T. M.
    Alsayegh, M.
    Birido, N.
    BREAST, 2013, 22 : S112 - S112
  • [9] Impact of National Comprehensive Cancer Network (NCCN) Genetic Testing Guidelines on Genetic Counseling Referral Patterns for Triple Negative Breast Cancer (TNBC) Patients
    Rakitin, I.
    Quigg, M.
    Nyhuis, M.
    Petersen, L.
    Nathanson, D.
    Davis, M.
    Susick, L.
    Proctor, E.
    Bensenhaver, J.
    Newman, L.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : S43 - S43
  • [10] RACIAL DISPARITIES IN ADHERENCE TO ESMO GUIDELINES FOR GERMLINE GENETIC TESTING IN GYNECOLOGIC CANCER PATIENTS WHO UNDERWENT SOMATIC TUMOR TESTING
    Karpel, Hannah
    Sasse, Simone
    Pothuri, Bhavana
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A200 - A200